Precigen to announce second quarter and first half 2023 financial results on august 9th

Germantown, md. , aug. 3, 2023 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the company will release second quarter and first half 2023 financial results on wednesday, august 9, 2023.
PGEN Ratings Summary
PGEN Quant Ranking